Skip to main content

Advertisement

SpringerLink
Log in

Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells

  • Molecular Toxicology
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Survivin is a member of the inhibitors of apoptosis protein (IAP) family and is highly expressed in various cancer cells. However, the molecular mechanisms regulating survivin expression remain unclear. In this study, we investigated the role of mitogen-activated protein kinases (MAPKs) in regulating survivin in the human lung adenocarcinoma cell line H1355 in response to arsenic trioxide (As(3+)). Our data indicated that As(3+) induced cytotoxicity accompanied by down-regulation of survivin, cleavage of Poly ADP-ribosyl polymerase (PARP) and activations of MAPKs, including ERK1/2, p38 and c-jun N-terminal kinase (JNK). We found that blockage of p38 or JNK activation attenuated the As(3+)-induced survivin down-regulation and PARP cleavage with significant reversal of cell viability, however, by only 5–8%. On the other hand, the MEK inhibitor PD098059 or the ubiquitin-proteasome inhibitor MG-132 exhibited little effect on survivin down-regulation and PARP cleavage induced by As(3+). In this study, we demonstrated that As(3+) could down-regulate survivin via activations of p38 and JNK in an ubiquitin-proteasome independent pathway and lead to cytotoxicity and apoptosis in the human lung adenocarcinoma cell line H1355.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Akao Y, Nakagawa Y, Akiyama K (1999) Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett 455:59–62

    Article  PubMed  CAS  Google Scholar 

  • Alberg AJ, Samet JM (2003) Epidemiology of lung cancer. Chest 123:21S–49S

    Article  PubMed  Google Scholar 

  • Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921

    Article  PubMed  CAS  Google Scholar 

  • Bargonetti J, Chicas A, White D, Prives C (1997) p53 represses Sp1 DNA binding and HIV-LTR directed transcription. Cell Mol Biol (Noisy-le-grand) 43:935–949

    CAS  Google Scholar 

  • Borellini F, Glazer RI (1993) Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J Biol Chem 268:7923–7928

    PubMed  CAS  Google Scholar 

  • Carter BZ, Milella M, Altieri DC, Andreeff M (2001) Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97:2784–2790

    Article  PubMed  CAS  Google Scholar 

  • Chao JI, Kuo PC, Hsu TS (2004) Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J Biol Chem 279:20267–20276

    Article  PubMed  CAS  Google Scholar 

  • Chen YC, Lin-Shiau SY, Lin JK (1998) Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 177:324–333

    Article  PubMed  CAS  Google Scholar 

  • Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, Chen Z (1997) Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89:3345–3353

    PubMed  CAS  Google Scholar 

  • Dai J, Weinberg RS, Waxman S, Jing Y (1999) Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268–277

    PubMed  CAS  Google Scholar 

  • De Schepper S, Bruwiere H, Verhulst T, Steller U, Andries L, Wouters W, Janicot M, Arts J, Van Heusden J (2003) Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin. J Pharmacol Exp Ther 304:881–888

    Article  PubMed  Google Scholar 

  • Gurr JR, Yih LH, Samikkannu T, Bau DT, Lin SY, Jan KY (2003) Nitric oxide production by arsenite. Mutat Res 533:173–182

    PubMed  CAS  Google Scholar 

  • Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M (2002) Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247–3257

    Article  PubMed  CAS  Google Scholar 

  • Huang C, Ma WY, Li J, Dong Z (1999a) Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Res 59:3053–3058

    CAS  Google Scholar 

  • Huang C, Ma WY, Li J, Goranson A, Dong Z (1999b) Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J Biol Chem 274:14595–14601

    Article  CAS  Google Scholar 

  • Iwama K, Nakajo S, Aiuchi T, Nakaya K (2001) Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer 92:518–526

    Article  PubMed  CAS  Google Scholar 

  • Joazeiro CA, Weissman AM (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell 102:549–552

    Article  PubMed  CAS  Google Scholar 

  • Kajiguchi T, Yamamoto K, Hossain K, Akhand AA, Nakashima I, Naoe T, Saito H, Emi N (2003) Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1. Leukemia 17:2189–2195

    Article  PubMed  CAS  Google Scholar 

  • Kang SH, Song JH, Kang HK, Kang JH, Kim SJ, Kang HW, Lee YK, Park DB (2003) Arsenic trioxide-induced apoptosis is independent of stress-responsive signaling pathways but sensitive to inhibition of inducible nitric oxide synthase in HepG2 cells. Exp Mol Med 35:83–90

    PubMed  CAS  Google Scholar 

  • Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071–5074

    PubMed  CAS  Google Scholar 

  • Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T (2000) Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 14:1743–1750

    Article  PubMed  CAS  Google Scholar 

  • LaCasse EC, Baird S, Korneluk RG, MacKenzie AE (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17:3247–3259

    Article  PubMed  Google Scholar 

  • Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584

    Article  PubMed  CAS  Google Scholar 

  • Li F, Ling X, Huang H, Brattain L, Apontes P, Wu J, Binderup L, Brattain MG (2005) Differential regulation of survivin expression and apoptosis by vitamin D(3) compounds in two isogenic MCF-7 breast cancer cell sublines. Oncogene 24:1389–1395

    Google Scholar 

  • Lin P, Wang HJ, Lee H, Lee HS, Wang SL, Hsueh YM, Tsai KJ, Chen CY (1999) NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan. J Toxicol Environ Health A 58:187–197

    Article  PubMed  CAS  Google Scholar 

  • Ling YH, Jiang JD, Holland JF, Perez-Soler R (2002) Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol Pharmacol 62:529–538

    Article  PubMed  CAS  Google Scholar 

  • Martin DW, Munoz RM, Subler MA, Deb S (1993) p53 binds to the TATA-binding protein-TATA complex. J Biol Chem 268:13062–13067

    PubMed  CAS  Google Scholar 

  • Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S (2002) Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21:2613–2622

    Article  PubMed  CAS  Google Scholar 

  • Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D’Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD et al (1992) p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171–180

    PubMed  CAS  Google Scholar 

  • Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17:2100–2104

    PubMed  CAS  Google Scholar 

  • Namgung U, Xia Z (2001) Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol Appl Pharmacol 174:130–138

    Article  PubMed  CAS  Google Scholar 

  • Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA, Zangemeister-Wittke U (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60:2805–2809

    PubMed  CAS  Google Scholar 

  • Park JW, Choi YJ, Jang MA, Baek SH, Lim JH, Passaniti T, Kwon TK (2001) Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells. Biochem Biophys Res Commun 286:726–734

    Article  PubMed  CAS  Google Scholar 

  • Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028–12032

    Article  PubMed  CAS  Google Scholar 

  • Shieh SY, Ikeda M, Taya Y, Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334

    Article  PubMed  CAS  Google Scholar 

  • Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315–5320

    PubMed  CAS  Google Scholar 

  • Travis WD, Travis LB, Devesa SS (1995) Lung cancer. Cancer 75:191–202

    Article  PubMed  CAS  Google Scholar 

  • Tsou TC, Yeh SC, Tsai FY, Chang LW (2004) The protective role of intracellular GSH status in the arsenite-induced vascular endothelial dysfunction. Chem Res Toxicol 17:208–217

    Article  PubMed  CAS  Google Scholar 

  • Wei L, Wang XW, Zuo WS (2004) Toxicity of arsenic trioxide to human lung adenocarcinoma cell line SPCA1 and its mechanism. Ai Zheng 23:1633–1638

    PubMed  CAS  Google Scholar 

  • Wiesenauer CA, Yip-Schneider MT, Wang Y, Schmidt CM (2004) Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J Am Coll Surg 198:410–421

    Article  PubMed  Google Scholar 

  • Wu X, Chen Z, Liu Z, Zhou H, You Y, Li W, Zou P (2004) Arsenic trioxide inhibits proliferation in K562 cells by changing cell cycle and survivin expression. J Huazhong Univ Sci Technolog Med Sci 24:342–344,353

    Google Scholar 

  • Yang L, Cao Z, Yan H, Wood WC (2003) Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 63:6815–6824

    PubMed  CAS  Google Scholar 

  • Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR (2000) The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113(Pt 23):4363–4371

    PubMed  CAS  Google Scholar 

  • Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW (2002) DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther 303:124–131

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by Grant EO-094-PP-02 from the National Health Research Institutes, Taiwan.

Author information

Authors and Affiliations

  1. Division of Environmental Health and Occupational Medicine, National Health Research Institutes, 35 Keyan Road, Miaoli County 350, Zhunan Town, Taiwan

    YaHsin Cheng, Louis W. Chang & Tsui-Chun Tsou

Authors
  1. YaHsin Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Louis W. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tsui-Chun Tsou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tsui-Chun Tsou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, Y., Chang, L.W. & Tsou, TC. Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Arch Toxicol 80, 310–318 (2006). https://doi.org/10.1007/s00204-005-0045-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-005-0045-1

Keywords

Search

Navigation